Sponsor content
106 result(s) found, displaying 61 to 70
-
Prescription medicine decision summaryTGA decision: Veklury (remdesivir) is provisionally approved to treat Coronavirus Disease 2019 (COVID-19) in adults and adolescents
-
Prescription medicine registrationActive ingredients: remdesivir.
-
-
Prescription medicine registrationActive ingredients: T Cells - axicabtagene ciloleucel, cryopreserved - T - Yescarta.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VEMLIDY tenofovir alafenamide (as fumarate) 25 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ODEFSEY emtricitabine (200 mg), rilpivirine (25 mg), tenofovir alafenamide (25 mg) fixed-dose combination tablet.
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DESCOVY 200 mg/25 mg ( 200 mg emtricitabine/25 mg tenofovir alafenamide) tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DESCOVY 200 mg/10 mg (200 mg emtricitabine/10 mg tenofovir alafenamide) tablet bottle.